Drug Shortage Report for LANSOPRAZOLE
Report ID | 67307 |
Drug Identification Number | 02357690 |
Brand name | LANSOPRAZOLE |
Common or Proper name | LANSOPRAZOLE |
Company Name | SANIS HEALTH INC |
Market Status | MARKETED |
Active Ingredient(s) | LANSOPRAZOLE |
Strength(s) | 30MG |
Dosage form(s) | CAPSULE (DELAYED RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-12-12 |
Actual start date | 2018-12-10 |
Estimated end date | Unknown |
Actual end date | 2020-12-10 |
Shortage status | Resolved |
Updated date | 2020-12-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2018-11-21 | French | Compare |
v1 | 2018-11-21 | English | Compare |